| Predicate |
Object |
| contentType |
Journal Article |
| issn |
2234-943X |
| pageRange |
43- |
| publicationName |
Frontiers in Oncology |
| startingPage |
43 |
| bibliographicCitation |
Slovin SR. Toward maximizing immunotherapy in metastatic castration-resistant prostate cancer - rationale for combinatorial approaches using chemotherapy. Front Oncol. 2012;2():43. PMID: 22662316; PMCID: PMC3362835. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63d5967aad942c3a70b43b5befb17741 |
| date |
2012 |
| identifier |
https://doi.org/10.3389/fonc.2012.00043
https://pubmed.ncbi.nlm.nih.gov/22662316
https://pubmed.ncbi.nlm.nih.gov/PMC3362835 |
| isPartOf |
https://portal.issn.org/resource/ISSN/2234-943X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39509 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Toward Maximizing Immunotherapy in Metastatic Castration-Resistant Prostate Cancer – Rationale for Combinatorial Approaches Using Chemotherapy |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 |